Journal of the American College of Cardiology
Appropriate Use Criteria
ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2019 Appropriate Use Criteria for Multimodality Imaging in the Assessment of Cardiac Structure and Function in Nonvalvular Heart DiseaseA Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and the Society of Thoracic Surgeons
John U. Doherty, Smadar Kort, Roxana Mehran, Paul Schoenhagen, Prem Soman, Gregory J. Dehmer, John U. Doherty, Paul Schoenhagen, Thomas M. Bashore, Nicole M. Bhave, Dennis A. Calnon, Blase Carabello, John Conte, Timm Dickfeld, Daniel Edmundowicz, Victor A. Ferrari, Michael E. Hall, Brian Ghoshhajra, Praveen Mehrotra, Tasneem Z. Naqvi, T. Brett Reece, Randall C. Starling, Molly Szerlip, Wendy S. Tzou and John B. Wong
Table A
Table A
Stages of Valvular Heart Disease
Stage | Definition | Description |
---|---|---|
A | At risk | Patients with risk factors for development of VHD |
B | Progressive | Patients with progressive VHD (mild to moderate severity and asymptomatic) |
C | Asymptomatic severe | Asymptomatic patients who meet criteria for severe VHD:
|
D | Symptomatic severe | Patients who have developed symptoms as a result of severe VHD |
Reproduced from Nishimura et al. (8).
VHD = valvular heart disease.
Advertisement